Biliary Cirrhosis

Biliary Cirrhosis

Overview

Chronic disorder with clinical/biochemical/morphologic long-continued cholestasis features (intra- or extrahepatic). 3 types:

• PRIMARY biliary cirrhosis — unknown etiology, intrahepatic bile duct destruction
• SECONDARY biliary cirrhosis — prolonged extrahepatic mechanical obstruction
• PRIMARY SCLEROSING CHOLANGITIS (+autoimmune cholangiopathy)

Etiology

PBC — unknown, but: MIDDLE-AGED WOMEN (M:F=1:9, →endocrine theory); familial/HLA links; ↑cholesterol→xanthoma/xanthelasma; hepatomegaly/CLD LATE features. AUTOIMMUNE origin most accepted: associated autoimmune disease (scleroderma/Sjögren’s/CREST/thyroiditis); ANTI-MITOCHONDRIAL Ab (IgG) >90%; ↑Ig(esp IgM); ↑immune complexes; ↓circulating T-cells; T-cell accumulation around ducts.

Secondary — mostly extrahepatic obstruction: gallstones(COMMONEST), biliary atresia, biliary tree/pancreatic head CA, postop strictures+ascending cholangitis.

PSC — unknown etiology, progressive inflammatory sclerosing obliterative process, BOTH intra+extrahepatic ducts. Postulated: viral/bacterial infection, immunologic injury, toxins, genetic predisposition.

Morphology

Gross(all): initially enlarged+greenish → later small/firm/coarsely micronodular. PSC: characteristic BEADING (irregular strictures+dilatation) of ducts.

PBC — diagnostic = chronic non-suppurative destructive cholangitis of intrahepatic ducts, 4 stages:

• I: florid duct lesions, confined portal tracts — destruction, bile plugs, inflammation, ±granulomas/follicles
• II: ductular proliferation, widespread, few normal ducts left, infiltrate extends beyond portal tracts, ±periportal Mallory bodies
• III: fibrous scarring interconnecting portal areas, ↓inflammation, ↓ducts
• IV: well-formed micronodular cirrhosis

Secondary — bile stasis+focal centrilobular necrosis; ductule proliferation/dilatation/rupture→BILE LAKES; sterile/pyogenic cholangitis (periductal polymorphs); progressive fibrosis→micronodular cirrhosis.

PSC-related — fibrosing cholangitis+periductal lymphocytes, SEGMENTAL; periductal fibrosis→lumen obliteration; intervening ducts dilated/tortuous/inflamed; late=full cholestasis+cirrhosis.

Clinical features

PBC — asymptomatic months-years, insidious. Cholestatic: pruritus, dark urine, pale stools, steatorrhoea, jaundice, skin pigmentation. EARLIEST lab = ↑ALKALINE PHOSPHATASE (precedes symptomatic cholestasis). ↑lipids→periorbital xanthelasma/joint xanthomas. Death: hepatic failure, variceal bleed, infection, liver/breast CA.

Secondary — suspect with prior gallstones/biliary surgery/ascending cholangitis.

PSC — asymptomatic OR cholestatic jaundice (↑ALP, pruritus, fatigue); late=CLD features. 3rd-5th decade, M:F=2:1 (REVERSE of PBC). Strong IBD association.

Comparison

Clinical relevance

PBC = 90% women + >90% anti-mitochondrial Ab positive = most efficient 2-fact diagnostic combo. ALP as EARLIEST lab finding in PBC — precedes symptoms, classic exam anchor. PSC’s IBD association + male preponderance (REVERSE of PBC’s female pattern) = key discriminator when biochemistry overlaps. All 3 forms share near-identical downstream biochemistry (↑ALP, conjugated bilirubin) despite totally different upstream mechanisms (autoimmune intrahepatic vs mechanical extrahepatic vs fibrosing cholangiopathy) — etiology+duct pathology differentiate them, not the labs.

---

Biliary Cirrhosis

Overview

Chronic disorder with clinical/biochemical/morphologic long-continued cholestasis features (intra- or extrahepatic). 3 types:

• PRIMARY biliary cirrhosis — unknown etiology, intrahepatic bile duct destruction
• SECONDARY biliary cirrhosis — prolonged extrahepatic mechanical obstruction
• PRIMARY SCLEROSING CHOLANGITIS (+autoimmune cholangiopathy)

Etiology

PBC — unknown, but: MIDDLE-AGED WOMEN (M:F=1:9, →endocrine theory); familial/HLA links; ↑cholesterol→xanthoma/xanthelasma; hepatomegaly/CLD LATE features. AUTOIMMUNE origin most accepted: associated autoimmune disease (scleroderma/Sjögren’s/CREST/thyroiditis); ANTI-MITOCHONDRIAL Ab (IgG) >90%; ↑Ig(esp IgM); ↑immune complexes; ↓circulating T-cells; T-cell accumulation around ducts.

Secondary — mostly extrahepatic obstruction: gallstones(COMMONEST), biliary atresia, biliary tree/pancreatic head CA, postop strictures+ascending cholangitis.

PSC — unknown etiology, progressive inflammatory sclerosing obliterative process, BOTH intra+extrahepatic ducts. Postulated: viral/bacterial infection, immunologic injury, toxins, genetic predisposition.

Morphology

Gross(all): initially enlarged+greenish → later small/firm/coarsely micronodular. PSC: characteristic BEADING (irregular strictures+dilatation) of ducts.

PBC — diagnostic = chronic non-suppurative destructive cholangitis of intrahepatic ducts, 4 stages:

• I: florid duct lesions, confined portal tracts — destruction, bile plugs, inflammation, ±granulomas/follicles
• II: ductular proliferation, widespread, few normal ducts left, infiltrate extends beyond portal tracts, ±periportal Mallory bodies
• III: fibrous scarring interconnecting portal areas, ↓inflammation, ↓ducts
• IV: well-formed micronodular cirrhosis

Secondary — bile stasis+focal centrilobular necrosis; ductule proliferation/dilatation/rupture→BILE LAKES; sterile/pyogenic cholangitis (periductal polymorphs); progressive fibrosis→micronodular cirrhosis.

PSC-related — fibrosing cholangitis+periductal lymphocytes, SEGMENTAL; periductal fibrosis→lumen obliteration; intervening ducts dilated/tortuous/inflamed; late=full cholestasis+cirrhosis.

Clinical features

PBC — asymptomatic months-years, insidious. Cholestatic: pruritus, dark urine, pale stools, steatorrhoea, jaundice, skin pigmentation. EARLIEST lab = ↑ALKALINE PHOSPHATASE (precedes symptomatic cholestasis). ↑lipids→periorbital xanthelasma/joint xanthomas. Death: hepatic failure, variceal bleed, infection, liver/breast CA.

Secondary — suspect with prior gallstones/biliary surgery/ascending cholangitis.

PSC — asymptomatic OR cholestatic jaundice (↑ALP, pruritus, fatigue); late=CLD features. 3rd-5th decade, M:F=2:1 (REVERSE of PBC). Strong IBD association.

Comparison

Clinical relevance

PBC = 90% women + >90% anti-mitochondrial Ab positive = most efficient 2-fact diagnostic combo. ALP as EARLIEST lab finding in PBC — precedes symptoms, classic exam anchor. PSC’s IBD association + male preponderance (REVERSE of PBC’s female pattern) = key discriminator when biochemistry overlaps. All 3 forms share near-identical downstream biochemistry (↑ALP, conjugated bilirubin) despite totally different upstream mechanisms (autoimmune intrahepatic vs mechanical extrahepatic vs fibrosing cholangiopathy) — etiology+duct pathology differentiate them, not the labs.

Biliary Cirrhosis

Overview

Biliary cirrhosis is a chronic disorder with clinical, biochemical, and morphologic features of long-continued cholestasis, of intrahepatic or extrahepatic origin. Three types:

• Primary biliary cirrhosis — destructive process of unknown etiology affecting intrahepatic bile ducts.
• Secondary biliary cirrhosis — from prolonged mechanical obstruction of extrahepatic biliary passages.
• Primary sclerosing cholangitis (and autoimmune cholangiopathy) — causing biliary cirrhosis.

Etiology

Primary biliary cirrhosis — etiology unknown, but several factors implicated:

1. Predominant in middle-aged women (M:F = 1:9) — raises the possibility of an endocrine origin.
2. Familial incidence observed, suggesting genetic influence and certain HLA associations.
3. Elevated cholesterol with xanthoma/xanthelasma; hepatomegaly and chronic liver disease are late features.
4. Autoimmune origin is the most widely accepted hypothesis, supported by: increased association with other autoimmune diseases (scleroderma, Sjögren’s syndrome, CREST syndrome, autoimmune thyroiditis); circulating anti-mitochondrial antibody (IgG) in >90% of cases; elevated immunoglobulins (particularly IgM); increased circulating immune complexes; decreased circulating T-cells; T-cell accumulation around bile ducts.

Secondary biliary cirrhosis — most cases from prolonged extrahepatic biliary obstruction:

1. Extrahepatic gallstones (commonest cause)
2. Biliary atresia
3. Cancer of the biliary tree or pancreatic head
4. Postoperative strictures with superimposed ascending cholangitis

Primary sclerosing cholangitis — chronic cholestatic syndrome of unknown etiology; progressive, inflammatory, sclerosing, obliterative process affecting both intra- and extrahepatic bile ducts. Postulated mechanisms: viral/bacterial infection, immunologic injury, toxins, genetic predisposition.

Morphology

Gross (all types): liver initially enlarged, characteristically greenish; later smaller, firmer, coarsely micronodular. In PSC-related cirrhosis: characteristic beading of intra-/extrahepatic bile ducts from irregular strictures and dilatation.

A. Primary biliary cirrhosis — diagnostic feature: chronic, non-suppurative, destructive cholangitis of intrahepatic bile ducts, evolving through 4 stages:

• Stage I: florid bile duct lesions confined to portal tracts — bile duct destruction, bile plugs, acute+chronic inflammatory infiltrate, ± granulomas/lymphoid follicles.
• Stage II: ductular proliferation — widespread ductal involvement with few normal ducts left; inflammatory infiltrate extends beyond portal tracts into parenchyma; periportal Mallory bodies may appear.
• Stage III: fibrous scarring interconnecting portal areas; diminished inflammation; reduced bile duct number.
• Stage IV: well-formed micronodular cirrhosis (over a period of years).

B. Secondary biliary cirrhosis — from prolonged extrahepatic obstruction:

1. Bile stasis, degeneration, focal centrilobular hepatocyte necrosis.
2. Proliferation, dilatation, rupture of portal bile ductules with bile lake formation.
3. Cholangitis (sterile or pyogenic) with periductal polymorph accumulation.
4. Progressive portal tract expansion by fibrosis → micronodular cirrhosis.

C. Cirrhosis due to primary sclerosing cholangitis:

1. Fibrosing cholangitis with periductal lymphocytic infiltrate, segmental involvement.
2. Periductal fibrosis, eventually obliterating affected duct lumina.
3. Intervening ducts dilated, tortuous, inflamed.
4. Late cases: cholestasis and full biliary cirrhosis picture.

Clinical Features

Primary biliary cirrhosis: may be asymptomatic for months to years, with insidious symptom onset. Fundamentally cholestatic — persistent pruritus, dark urine, pale stools, steatorrhoea, jaundice, skin pigmentation. Earliest lab finding: markedly elevated alkaline phosphatase. Elevated serum lipids accompanied by periorbital xanthelasma/joint xanthomas. Death from hepatic failure, variceal bleeding, intercurrent infection, or concomitant liver/breast cancer.

Secondary biliary cirrhosis: suspected in patients with prior gallstones, biliary tract surgery, or ascending cholangitis features.

Primary sclerosing cholangitis: may be asymptomatic or show cholestatic jaundice features (raised alkaline phosphatase, pruritus, fatigue); late cases show chronic liver disease manifestations. Occurs 3rd–5th decade, 2:1 male preponderance. Strongly associated with inflammatory bowel disease.

Comparison of the Three Forms

Clinical Relevance

• Primary biliary cirrhosis’s near-90%-women demographic combined with its anti-mitochondrial antibody positivity in >90% of cases is the single most efficient two-fact combination for suspecting/confirming the diagnosis clinically.
• The alkaline phosphatase elevation as the “earliest lab finding” in primary biliary cirrhosis is a classic exam anchor — remember it precedes symptomatic cholestasis rather than following it.
• PSC’s association with inflammatory bowel disease (and its male preponderance, the reverse of PBC’s female preponderance) is the key discriminator when both conditions present with similar cholestatic biochemistry — think IBD history and sex distribution first.
• The three forms share nearly identical downstream biochemistry (raised ALP, conjugated bilirubin) despite completely different upstream mechanisms (autoimmune intrahepatic destruction vs mechanical extrahepatic obstruction vs fibrosing cholangiopathy) — the etiology and duct-level pathology, not the labs, is what actually differentiates them.

---

Biliary Cirrhosis

Overview

Biliary cirrhosis is a chronic disorder with clinical, biochemical, and morphologic features of long-continued cholestasis, of intrahepatic or extrahepatic origin. Three types:

• Primary biliary cirrhosis — destructive process of unknown etiology affecting intrahepatic bile ducts.
• Secondary biliary cirrhosis — from prolonged mechanical obstruction of extrahepatic biliary passages.
• Primary sclerosing cholangitis (and autoimmune cholangiopathy) — causing biliary cirrhosis.

Etiology

Primary biliary cirrhosis — etiology unknown, but several factors implicated:

1. Predominant in middle-aged women (M:F = 1:9) — raises the possibility of an endocrine origin.
2. Familial incidence observed, suggesting genetic influence and certain HLA associations.
3. Elevated cholesterol with xanthoma/xanthelasma; hepatomegaly and chronic liver disease are late features.
4. Autoimmune origin is the most widely accepted hypothesis, supported by: increased association with other autoimmune diseases (scleroderma, Sjögren’s syndrome, CREST syndrome, autoimmune thyroiditis); circulating anti-mitochondrial antibody (IgG) in >90% of cases; elevated immunoglobulins (particularly IgM); increased circulating immune complexes; decreased circulating T-cells; T-cell accumulation around bile ducts.

Secondary biliary cirrhosis — most cases from prolonged extrahepatic biliary obstruction:

1. Extrahepatic gallstones (commonest cause)
2. Biliary atresia
3. Cancer of the biliary tree or pancreatic head
4. Postoperative strictures with superimposed ascending cholangitis

Primary sclerosing cholangitis — chronic cholestatic syndrome of unknown etiology; progressive, inflammatory, sclerosing, obliterative process affecting both intra- and extrahepatic bile ducts. Postulated mechanisms: viral/bacterial infection, immunologic injury, toxins, genetic predisposition.

Morphology

Gross (all types): liver initially enlarged, characteristically greenish; later smaller, firmer, coarsely micronodular. In PSC-related cirrhosis: characteristic beading of intra-/extrahepatic bile ducts from irregular strictures and dilatation.

A. Primary biliary cirrhosis — diagnostic feature: chronic, non-suppurative, destructive cholangitis of intrahepatic bile ducts, evolving through 4 stages:

• Stage I: florid bile duct lesions confined to portal tracts — bile duct destruction, bile plugs, acute+chronic inflammatory infiltrate, ± granulomas/lymphoid follicles.
• Stage II: ductular proliferation — widespread ductal involvement with few normal ducts left; inflammatory infiltrate extends beyond portal tracts into parenchyma; periportal Mallory bodies may appear.
• Stage III: fibrous scarring interconnecting portal areas; diminished inflammation; reduced bile duct number.
• Stage IV: well-formed micronodular cirrhosis (over a period of years).

B. Secondary biliary cirrhosis — from prolonged extrahepatic obstruction:

1. Bile stasis, degeneration, focal centrilobular hepatocyte necrosis.
2. Proliferation, dilatation, rupture of portal bile ductules with bile lake formation.
3. Cholangitis (sterile or pyogenic) with periductal polymorph accumulation.
4. Progressive portal tract expansion by fibrosis → micronodular cirrhosis.

C. Cirrhosis due to primary sclerosing cholangitis:

1. Fibrosing cholangitis with periductal lymphocytic infiltrate, segmental involvement.
2. Periductal fibrosis, eventually obliterating affected duct lumina.
3. Intervening ducts dilated, tortuous, inflamed.
4. Late cases: cholestasis and full biliary cirrhosis picture.

Clinical Features

Primary biliary cirrhosis: may be asymptomatic for months to years, with insidious symptom onset. Fundamentally cholestatic — persistent pruritus, dark urine, pale stools, steatorrhoea, jaundice, skin pigmentation. Earliest lab finding: markedly elevated alkaline phosphatase. Elevated serum lipids accompanied by periorbital xanthelasma/joint xanthomas. Death from hepatic failure, variceal bleeding, intercurrent infection, or concomitant liver/breast cancer.

Secondary biliary cirrhosis: suspected in patients with prior gallstones, biliary tract surgery, or ascending cholangitis features.

Primary sclerosing cholangitis: may be asymptomatic or show cholestatic jaundice features (raised alkaline phosphatase, pruritus, fatigue); late cases show chronic liver disease manifestations. Occurs 3rd–5th decade, 2:1 male preponderance. Strongly associated with inflammatory bowel disease.

Comparison of the Three Forms

Clinical Relevance

• Primary biliary cirrhosis’s near-90%-women demographic combined with its anti-mitochondrial antibody positivity in >90% of cases is the single most efficient two-fact combination for suspecting/confirming the diagnosis clinically.
• The alkaline phosphatase elevation as the “earliest lab finding” in primary biliary cirrhosis is a classic exam anchor — remember it precedes symptomatic cholestasis rather than following it.
• PSC’s association with inflammatory bowel disease (and its male preponderance, the reverse of PBC’s female preponderance) is the key discriminator when both conditions present with similar cholestatic biochemistry — think IBD history and sex distribution first.
• The three forms share nearly identical downstream biochemistry (raised ALP, conjugated bilirubin) despite completely different upstream mechanisms (autoimmune intrahepatic destruction vs mechanical extrahepatic obstruction vs fibrosing cholangiopathy) — the etiology and duct-level pathology, not the labs, is what actually differentiates them.

Biliary Cirrhosis

• The four stages of primary biliary cirrhosis progression (florid duct lesions → ductular proliferation → fibrous scarring → micronodular cirrhosis)
• Three-way comparison of primary biliary cirrhosis, secondary biliary cirrhosis, and primary sclerosing cholangitis by etiology, demographics, and duct pathology

---

Biliary Cirrhosis

• The four stages of primary biliary cirrhosis progression (florid duct lesions → ductular proliferation → fibrous scarring → micronodular cirrhosis)
• Three-way comparison of primary biliary cirrhosis, secondary biliary cirrhosis, and primary sclerosing cholangitis by etiology, demographics, and duct pathology